Analystreport

BridgeBio Pharma (NASDAQ:BBIO) had its "outperform" rating reaffirmed by analysts at Evercore ISI.

BridgeBio Pharma, Inc.  (BBIO) 
Last bridgebio pharma, inc. earnings: 3/2 08:29 am Check Earnings Report